Advertisement

Topics

CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy

23:33 EDT 18 Oct 2016 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
NESS ZIONA, Israel, October 19, 2016 /PRNewswire/ -- CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human collagen) technology for tissue repair products, today announced that it ha...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "CollPlant Receives CE Mark for Vergenix™STR for Treatment of Tendinopathy"

Quick Search
Advertisement
 

Relevant Topics

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...